While a trend toward decreased ACAA1 mRNA levels was observed in advanced-stage (III/IV) NPC patients, this association did not reach statistical significance (Figure 1B, p > 0.05), suggesting that ACAA1 downregulation is a persistent event in NPC pathogenesis. Here, ACAA1 is linked to nasopharyngeal carcinoma.